Back
HFA Premium Access

Who ARNI the best responders among patients with LVEF<35%?

Session: Poster Session 2 - Pharmacology and Pharmacotherapy
Topic: Cardiovascular Pharmacotherapy, Other
Speaker: Doctor J. De Almeida (Coimbra, PT)
Event: Heart Failure 2019

Congress Presentation

About the speaker

Doctor Jose Paulo Lopes De Almeida

University Hospitals of Coimbra, Coimbra (Portugal)
1 presentation
0 follower

12 more presentations in this session

Optimal administration timing of thiazide diuretics for sequential nephron blockade in cardiovascular patients receiving loop diuretics

Speaker: Doctor J. Fallon (Cleveland, US)

Access
Abstract
Slides
Thumbnail

Super-response to sacubitril valsartan: prevalence and clinical profile

Speaker: Mr C. Moliner-Abos (Barcelona, ES)

Access
Abstract
Thumbnail

Rationale, design and baseline characteristics of the Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) randomized controlled trial

Speaker: Professor M. Ledwidge (Dublin, IE)

Access
Abstract
Thumbnail

Effect of empagliflozin on hydroelectrolytic balance in patients with heart failure with reduced ejection fraction

Speaker: Doctor S. Del Prado Diaz (Madrid, ES)

Access
Abstract
Slides
Thumbnail

Iron therapy in heart failure with preserved vs depressed ejection fraction

Speaker: Assistant Professor G. Alonso Salinas (Pamplona, ES)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 2 - Pharmacology and Pharmacotherapy

Speakers: Doctor J. De Almeida, Doctor J. Fallon, Mr C. Moliner-Abos, Professor M. Ledwidge, Doctor S. Del Prado Diaz...
Access
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb